Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Glutamate is the brain's main excitatory neurotransmitter, and when levels run too high, nerve cells fire more easily and pain signals amplify. Research links elevated glutamate in the brain and spinal cord to central sensitization, the process behind chronic conditions like fibromyalgia, migraine, and neuropathic pain. Studies using MRI spectroscopy have found higher glutamate concentrations in pain-processing regions such as the insula, and these levels often drop as symptoms improve. Excess glutamate can also trigger excitotoxicity, where overstimulated neurons become damaged, which may help explain why some pain becomes persistent. There are several factors that influence glutamate balance, including sleep, stress, medications, and diet, so see below to understand more.
Because glutamate-related pain can overlap with many other conditions, understanding your own pattern of symptoms matters before deciding what to do next. A free, instant, online symptom check can help you organize what you are feeling, spot possible causes, and clarify which type of care makes sense, giving you a clearer path forward instead of guessing.
Last reviewed for medical accuracy: 08/18/2026
Glutamate is the brain’s primary excitatory neurotransmitter. It plays a vital role in learning, memory and normal sensory processing. However, when glutamate signaling becomes excessive—especially within the spinal cord and cerebrospinal fluid—people may experience heightened pain sensitivity. Researchers have found that elevated cerebrospinal fluid glutamate levels often go hand-in-hand with chronic pain conditions. Understanding why and how this happens can help you discuss symptoms more effectively with your healthcare provider.
• Glutamate is an amino acid used by nerve cells to send excitatory signals.
• It activates receptors—most notably NMDA (N-methyl-D-aspartate) receptors—on neurons, leading to electrical impulses.
• Proper glutamate function supports normal brain activity: learning, memory and basic reflexes.
When glutamate levels are balanced, neuronal communication proceeds smoothly. But too much glutamate, especially in the cerebrospinal fluid that bathes the brain and spinal cord, can overstimulate neurons. This overstimulation can trigger pain pathways to become hypersensitive—a phenomenon called central sensitization.
Research indicates that people with chronic pain often show higher glutamate concentrations in their cerebrospinal fluid compared to healthy controls. Key mechanisms include:
NMDA Receptor Overactivation
Excess glutamate continually stimulates NMDA receptors in the dorsal horn of the spinal cord. Over time, this “wind-up” effect lowers the threshold for pain signals, making even mild stimuli feel painful (hyperalgesia).
Central Sensitization
Prolonged excitatory signaling rewires neural circuits in the spinal cord and brain. As a result, ordinary touch or movement can trigger pain (allodynia).
Neuroinflammation
Glutamate spill-over can activate glial cells (support cells in the nervous system), releasing inflammatory molecules that further boost pain signaling.
Elevated cerebrospinal fluid glutamate levels have been documented in several chronic pain disorders:
In each of these conditions, studies show a link between higher CSF glutamate and more intense pain, greater disability and poorer quality of life.
Several factors can contribute to excessive glutamate in the cerebrospinal fluid:
Because CSF glutamate correlates with pain severity, it’s being studied as a potential biomarker. Measuring glutamate levels could help:
Treatments aimed at lowering glutamate activity or blocking its receptors may reduce pain:
If you’ve been experiencing unexplained or persistent pain, consider taking proactive steps:
These steps can help you gather information and prepare for a productive conversation with your healthcare provider.
While mild, short-lived pain is normal, persistent or severe pain should not be ignored. Speak to a doctor if you experience:
A healthcare professional can evaluate whether elevated cerebrospinal fluid glutamate levels may be playing a role and recommend appropriate testing or treatment.
Research into excitatory neurotransmitters and pain continues to evolve. In the future, precise measurements of CSF glutamate may guide personalized pain therapies. For now, understanding the connection between glutamate and pain can empower you to:
Remember, knowledge is power. By staying informed, you can take active steps toward better pain management and improved quality of life.
If you have any concerns about your symptoms or suspect a serious condition, please speak to a doctor right away. For an initial, hassle-free check, try a free, online symptom check, using the doctor approved Ubie Symptom Checker.
(References)
* Gogas KR. Glutamate-based therapeutic approaches: NR2B receptor antagonists. Curr Opin Pharmacol. 2006 Feb;6(1):68-74. doi: 10.1016/j.coph.2005.11.001. Epub 2005 Dec 22. PMID: 16376149.
* Guindon J, Lin JS. Inflammatory pain models with capsaicin or glutamate injections: are they comparable and reproducible? Clin Exp Pharmacol Physiol. 2014 Dec;41(12):947-9. doi: 10.1111/1440-1681.12306. PMID: 25469791.
* Malet M, Brumovsky PR. VGLUTs and Glutamate Synthesis-Focus on DRG Neurons and Pain. Biomolecules. 2015 Dec 2;5(4):3416-37. doi: 10.3390/biom5043416. Epub 2015 Dec 2. PMID: 26633536; PMCID: PMC4693284.
* Zhuo M. Ionotropic glutamate receptors contribute to pain transmission and chronic pain. Neuropharmacology. 2017 Jan;112(Pt A):228-234. doi: 10.1016/j.neuropharm.2016.08.014. Epub 2016 Aug 16. PMID: 27543416.
* Zhang MM, Geng AQ, Chen K, Wang J, Wang P, Qiu XT, Gu JX, Fan HW, Zhu DY, Yang SM, Chen QY, Zhou ZX, Fan BY, Bai Y, Xing KK, Feng JM, Wang JD, Chen Y, Lu YC, Liang Y, Cao P, Kaang BK, Zhuo M, Li YQ, Chen T. Glutamatergic synapses from the insular cortex to the basolateral amygdala encode observational pain. Neuron. 2022 Jun 15;110(12):1993-2008.e6. doi: 10.1016/j.neuron.2022.03.030. Epub 2022 Apr 19. PMID: 35443154.
* Ackermann PW, Alim MA, Pejler G, Peterson M. Tendon pain - what are the mechanisms behind it? Scand J Pain. 2023 Jan 27;23(1):14-24. doi: 10.1515/sjpain-2022-0018. Epub 2022 Jul 18. PMID: 35850720.
* Xie RG, Xu GY, Wu SX, Luo C. Presynaptic glutamate receptors in nociception. Pharmacol Ther. 2023 Nov;251:108539. doi: 10.1016/j.pharmthera.2023.108539. Epub 2023 Sep 30. PMID: 37783347.
* Qian X, Zhao X, Yu L, Yin Y, Zhang XD, Wang L, Li JX, Zhu Q, Luo JL. Current status of GABA receptor subtypes in analgesia. Biomed Pharmacother. 2023 Dec;168:115800. doi: 10.1016/j.biopha.2023.115800. Epub 2023 Nov 6. PMID: 37935070.
* Sabnis SS, S Narasimhan KK, Chettiar PB, Gakare SG, Shelkar GP, Asati DG, Thakur SS, Dravid SM. Intravenous recombinant cerebellin 1 treatment restores signalling by spinal glutamate delta 1 receptors and mitigates chronic pain. Br J Pharmacol. 2024 May;181(9):1421-1437. doi: 10.1111/bph.16296. Epub 2024 Jan 24. PMID: 38044332; PMCID: PMC11288346.
* Sirucek L, De Schoenmacker I, Gorrell LM, Lütolf R, Langenfeld A, Baechler M, Wirth B, Hubli M, Zölch N, Schweinhardt P. The periaqueductal gray in chronic low back pain: dysregulated neurotransmitters and function. Pain. 2025 May 15;166(7):1690-1705. doi: 10.1097/j.pain.0000000000003617. Epub 2025 May 15. PMID: 40372313; PMCID: PMC12168810.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.